See more : Microsoft Corporation (4338.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Max Healthcare Institute Limited (MAXHEALTH.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Max Healthcare Institute Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Hindustan Motors Limited (HINDMOTORS.NS) Income Statement Analysis – Financial Results
- Battery Age Minerals Ltd (BM8.AX) Income Statement Analysis – Financial Results
- Adyen N.V. (1N8.DE) Income Statement Analysis – Financial Results
- Amplitude Healthcare Acquisition Corporation (AMHCU) Income Statement Analysis – Financial Results
- Daesang Corporation (001685.KS) Income Statement Analysis – Financial Results
Max Healthcare Institute Limited (MAXHEALTH.BO)
About Max Healthcare Institute Limited
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including bariatric surgery/metabolic, bone marrow transplant, cancer/oncology, cardiac science, endocrinology and diabetes, eye care, gastroenterology, hepatology and endoscopy, kidney transplant, laparoscopic, liver transplant, neuro science, orthopedics, robotic surgery, urology, and vascular surgery. The company provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres in Delhi and National Capital Region, Maharashtra, Punjab, Uttar Pradesh, and Uttarakhand. The company is based in Gurugram, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54.06B | 44.89B | 38.83B | 24.82B | 10.33B | 16.71B | 17.12B | 14.38B | 12.57B | 7.90B | 9.44B |
| Cost of Revenue | 20.53B | 9.22B | 9.23B | 5.94B | 2.17B | 3.65B | 4.49B | 4.23B | 3.99B | 4.36B | 5.39B |
| Gross Profit | 33.53B | 35.67B | 29.60B | 18.88B | 8.16B | 13.06B | 12.62B | 10.15B | 8.58B | 3.53B | 4.06B |
| Gross Profit Ratio | 62.03% | 79.46% | 76.23% | 76.06% | 78.96% | 78.14% | 73.74% | 70.58% | 68.28% | 44.73% | 42.95% |
| Research & Development | 5.11M | 3.60M | -1.60B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 11.17B | 11.27B | 9.08B | 6.22B | 2.90B | 4.56B | 4.47B | 4.16B | 3.80B | 252.50M | 0.00 |
| Selling & Marketing | 0.00 | 575.50M | 446.20M | 167.50M | 563.90M | 217.10M | 319.50M | 291.10M | 283.00M | 156.20M | 132.20M |
| SG&A | 11.17B | 11.84B | 9.53B | 6.39B | 3.46B | 4.77B | 4.79B | 4.45B | 4.09B | 408.70M | 132.20M |
| Other Expenses | 0.00 | 74.00M | 52.50M | 50.70M | 67.40M | 65.40M | 45.00M | 108.70M | 111.80M | 0.00 | 0.00 |
| Operating Expenses | 11.17B | 25.22B | 21.67B | 15.99B | 7.63B | 12.50B | 12.38B | 9.57B | 8.43B | 3.79B | 4.27B |
| Cost & Expenses | 31.70B | 34.44B | 30.90B | 21.94B | 9.80B | 16.15B | 16.87B | 13.80B | 12.42B | 8.15B | 9.66B |
| Interest Income | 1.53B | 1.12B | 750.90M | 767.30M | 369.00M | 116.10M | 132.70M | 10.40M | 6.00M | 122.70M | 425.70M |
| Interest Expense | 598.90M | 713.20M | 900.10M | 1.71B | 781.90M | 961.80M | 913.60M | 953.80M | 645.00M | 0.00 | 0.00 |
| Depreciation & Amortization | 2.45B | 2.32B | 2.21B | 1.74B | 456.40M | 1.03B | 944.20M | 955.10M | 912.10M | 494.40M | 514.50M |
| EBITDA | 16.70B | 13.80B | 10.61B | 2.85B | 1.42B | 2.12B | 1.67B | 1.83B | 1.40B | 218.10M | 283.20M |
| EBITDA Ratio | 30.90% | 30.84% | 27.91% | 22.32% | 13.23% | 12.45% | 9.49% | 14.49% | 10.68% | 2.76% | 3.00% |
| Operating Income | 22.36B | 10.26B | 9.33B | 2.54B | 482.20M | 542.60M | 209.60M | 466.50M | 124.70M | -276.30M | -231.30M |
| Operating Income Ratio | 41.36% | 22.87% | 24.03% | 10.22% | 4.67% | 3.25% | 1.22% | 3.24% | 0.99% | -3.50% | -2.45% |
| Total Other Income/Expenses | -8.70B | -7.81B | -5.77B | -3.22B | -398.80M | -477.60M | -510.00M | -532.20M | -336.10M | -105.10M | -4.57B |
| Income Before Tax | 13.65B | 10.64B | 7.39B | -686.50M | 127.80M | 83.20M | -264.90M | 47.00M | -189.60M | -381.40M | -642.90M |
| Income Before Tax Ratio | 25.26% | 23.70% | 19.03% | -2.77% | 1.24% | 0.50% | -1.55% | 0.33% | -1.51% | -4.83% | -6.81% |
| Income Tax Expense | 3.08B | -397.90M | 1.34B | 458.50M | -1.30M | 85.10M | 22.40M | -43.50M | 36.50M | 0.00 | 3.60M |
| Net Income | 10.58B | 11.04B | 6.05B | -1.38B | 589.90M | -30.10M | -301.60M | 90.50M | -226.10M | -381.40M | -646.50M |
| Net Income Ratio | 19.56% | 24.58% | 15.58% | -5.54% | 5.71% | -0.18% | -1.76% | 0.63% | -1.80% | -4.83% | -6.85% |
| EPS | 10.89 | 11.38 | 6.25 | -1.59 | 1.10 | -0.06 | -0.56 | 0.17 | -0.41 | -0.85 | -1.57 |
| EPS Diluted | 10.84 | 11.36 | 6.24 | -1.59 | 1.10 | -0.06 | -0.55 | 0.17 | -0.41 | -0.85 | -1.57 |
| Weighted Avg Shares Out | 971.57M | 970.06M | 967.47M | 863.20M | 537.24M | 537.24M | 537.20M | 536.60M | 545.71M | 448.71M | 411.30M |
| Weighted Avg Shares Out (Dil) | 975.46M | 971.71M | 969.38M | 863.20M | 537.24M | 545.71M | 545.71M | 545.71M | 545.71M | 451.11M | 413.02M |
Source: https://incomestatements.info
Category: Stock Reports